More on RLAY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Relay Therapeutics (NQ:RLAY)
Delayed: 9.89 +0.25 (2.59%)
Prev. Close $9.64  
Open$9.31 
52 Wk High$ 
52 Wk Low$ 
Day High$9.91 
Day Low$9.06 
P/E N/A  
EPS$ 
Volume1,420,071 

Friends, Peers and Foes (?): GSK, CNTX, BCAX, BNTX, NVS (more...)

Mar 3, 2026 05:08 AM Relay Therapeutics (RLAY) Reiterated at Market Outperform by Citizens Before ESMO Congress
Mar 2, 2026 05:31 PM Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Feb 27, 2026 07:03 AM Relay Therapeutics (RLAY) PT Raised to $15 at Wells Fargo
Feb 26, 2026 04:39 PM Form S-8 Relay Therapeutics, Inc.
Feb 26, 2026 04:25 PM Form 10-K Relay Therapeutics, Inc. For: Dec 31
Feb 26, 2026 04:16 PM Form 8-K Relay Therapeutics, Inc. For: Feb 26
Feb 26, 2026 04:05 PM Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Feb 23, 2026 04:05 PM Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Feb 19, 2026 05:55 PM Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Feb 17, 2026 04:48 PM Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Casdin Capital, LLC
View All Articles

Entities mentioned with RLAY

View All Entities